Australia's most trusted
source of pharma news
Monday, 20 May 2024
Posted 6 May 2024 AM
Sun Pharma has become the third company to register biosimilars of Eli Lilly's osteoporosis treatment Forteo.
Gedeon Richter's biosimilar Terrosa has until recently been the only teriparatide-containing medicine listed on the PBS since Lilly pulled its drug from the scheme in 2022.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.